Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Predictors of biochemical progression-free survival in men who receive radiation therapy after prostatectomy

Nature Clinical Practice Urology volume 5, pages 192–193 (2008)Cite this article

van der Kwast TH et al. (2007) Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911. J Clin Oncol 25: 4178–4186

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bolla M et al. (2005) Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 366: 572–578

    Article  Google Scholar 

  2. Collette L et al. (2005) Patients at high risk of progression after radical prostatectomy: do they all benefit from immediate post-operative irradiation? (EORTC trial 22911). Eur J Cancer 41: 2662–2272

    Article  Google Scholar 

  3. van der Kwast TH et al. (2006) Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911). Virchows Arch 449: 428–434

    Article  Google Scholar 

  4. Stephenson AJ et al. (2007) Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 25: 2035–2041

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Murphy, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Department of Radiology, Memorial Sloan–Kettering Cancer Center, 1275 York Avenue, C278, New York, NY 10021, USA pucard@mskcc.org

Authors and Affiliations

  1. D Pucar is a Holman Research Pathway Radiology Resident at the Department of Radiology, Memorial Sloan–Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA.,

    Darko Pucar

Authors
  1. Darko Pucar
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pucar, D. Predictors of biochemical progression-free survival in men who receive radiation therapy after prostatectomy. Nat Rev Urol 5, 192–193 (2008). https://doi.org/10.1038/ncpuro1055

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro1055

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing